Published in Ann Allergy on January 01, 1987
Bullous pemphigoid in infants: characteristics, diagnosis and treatment. Orphanet J Rare Dis (2014) 0.77
Protective effect of antibody to parainfluenza type 1 virus. N Engl J Med (1966) 5.97
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Congenital rubella. Clinicopathologic, virologic, and immunologic studies. Am J Dis Child (1965) 2.82
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Pseudomonas colonization in cystic fibrosis. A study of 160 patients. JAMA (1978) 2.42
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
The mechanism of respiratory failure in paraneoplastic pemphigus. N Engl J Med (1999) 2.21
Impaired in vitro cell-mediated immunity to rubella virus during pregnancy. N Engl J Med (1973) 2.06
Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med (1999) 1.95
Treatment of pyoderma gangrenosum with intravenous immunoglobulin. Br J Dermatol (2007) 1.95
A 51 Cr microassay technique for cell-mediated immunity to viruses. J Immunol (1973) 1.91
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption. Arch Dermatol (1993) 1.86
Immunoglobulins in serum and nasal secretions following infection with type 1 parainfluenza virus and injection of inactivated vaccines. J Immunol (1967) 1.79
Respiratory syncytial virus neutralizing activity in nasal secretions following natural infection. Proc Soc Exp Biol Med (1969) 1.79
Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol (1999) 1.69
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome. J Clin Invest (1990) 1.67
Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation. JAMA (1992) 1.60
Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer. J Invest Dermatol (1985) 1.60
Chronic idiopathic acrocyanosis. J Am Acad Dermatol (2001) 1.57
Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol (2000) 1.46
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
Induction of acantholysis in organ explant culture by penicillamine and captopril. Arch Dermatol (1989) 1.42
Role of food allergy in serous otitis media. Ann Allergy (1994) 1.40
Familial thymic aplasia. Attempted reconstitution with fetal thymus in a Millipore diffusion chamber. N Engl J Med (1972) 1.37
In vitro synergism between interferons and human lymphotoxin: enhancement of lymphotoxin-induced target cell killing. J Immunol (1983) 1.35
Studies of cell-mediated immunity to measles virus by in vitro lymphocyte-mediated cytotoxicity. J Infect Dis (1974) 1.34
Glomerular microtubules of systemic lupus erythematosus. Lancet (1970) 1.33
Paraneoplastic pemphigus in association with Castleman's disease. Br J Dermatol (2003) 1.32
Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N Engl J Med (1969) 1.32
Ideal target organism for quantitative bactericidal assays. Infect Immun (1978) 1.31
Maturation of the rabbit alveolar macrophage during animal development. III. Phagocytic and bactericidal functions. Pediatr Res (1977) 1.31
Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis (1977) 1.26
Increased susceptibility of males to infection. Lancet (1969) 1.25
Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans. J Am Acad Dermatol (1999) 1.23
Development of specific cellular and humoral immune responses in children immunized with live rubella virus vaccine. J Infect Dis (1974) 1.22
Pemphigus and bullous pemphigoid. Lancet (1999) 1.20
Use of cryopreserved virus-infected target cells in a lymphocytotoxicity 51Cr release microassay for cell-mediated immunity to cytomegalovirus. Infect Immun (1976) 1.20
Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest (1998) 1.20
Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis. Infect Immun (1975) 1.18
Age-dependent susceptibility of neonatal rats to group B streptococcal type III infection: correlation of severity of infection and response of myeloid pools. Infect Immun (1982) 1.16
Biologic significance of the secretory A immunoglobulins. Pediatrics (1971) 1.16
Enhancement of Pseudomonas aeruginosa lung clearance after local immunization with a temperature-sensitive mutant. Infect Immun (1983) 1.14
You Can Control Asthma: evaluation of an asthma education program for hospitalized inner-city children. Patient Educ Couns (1991) 1.14
Effect of chemotactins released by Staphylococcus aureus and Pseudomonas aeruginosa on the murine respiratory tract. Infect Immun (1985) 1.14
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
Congenital anaemia after transplacental B19 parvovirus infection. Lancet (1994) 1.13
The effectiveness of mycophenolate mofetil in refractory pyoderma gangrenosum. Arch Dermatol (1998) 1.12
Identification of the cell population involved in viral-specific cell-mediated cytotoxicity in man: evidence for T cell specificity. J Immunol (1975) 1.12
Esophageal lichen planus: case report and review of the literature. Am J Surg Pathol (2000) 1.10
Herpes simplex encephalitis: virologic and serologic study of a patient treated with an interferon inducer. J Pediatr (1971) 1.08
Maturation of the rabbit alveolar macrophage during animal development. I. Perinatal influx into alveoli and ultrastructural differentiation. Pediatr Res (1977) 1.08
Impaired lung defenses against Staphylococcus aureus in mice with hereditary deficiency of the fifth component of complement. Infect Immun (1983) 1.06
Periplakin and envoplakin are target antigens in canine and human paraneoplastic pemphigus. J Am Acad Dermatol (1999) 1.06
Paraneoplastic pemphigus: the role of tumours and drugs. Br J Dermatol (2001) 1.06
Characterization of human serum and nasal hemagglutinating antibody to Francisella tularensis. J Immunol (1967) 1.05
Antiviral chemotherapy and neonatal herpes simplex virus infecition: a pilot study--experience with adenine arabinoside (ARA-A). Pediatrics (1975) 1.04
Chemotactic and candidacidal responses of rabbit alveolar macrophages during postnatal development and the modulating roles of surfactant in these responses. Infect Immun (1984) 1.04
Inflammatory responses to Pseudomonas aeruginosa and Staphylococcus aureus in the murine lung. Eur J Respir Dis (1985) 1.03
Poly I:C induces development of diabetes mellitus in BB rat. Diabetes (1992) 1.02
Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds. Infect Immun (1986) 1.01
The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. J Invest Dermatol (1985) 1.01
Immunoglobulin responses in serum and nasal secretions after natural adenovirus infections. J Immunol (1969) 1.00
Temperature-sensitive mutants of Pseudomonas aeruginosa: isolation and preliminary immunological evaluation. Infect Immun (1982) 1.00
Antibodies to DNA in childhood systemic lupus erythematosus. J Pediatr (1971) 0.99
Poly I:C accelerates development of diabetes mellitus in diabetes-prone BB rat. Diabetes (1992) 0.99
Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol (1989) 0.98
Chemotactic responses of various differentiational stages of neutrophils from human cord and adult blood. Infect Immun (1982) 0.98
Accelerated decay of glucose 6-phosphate dehydrogenase activity in chronic granulomatous disease. Pediatr Res (1970) 0.95
Accuracy of indirect immunofluorescence testing in the diagnosis of paraneoplastic pemphigus. J Am Acad Dermatol (1995) 0.95
Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol (1984) 0.94
Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. J Rheumatol (1987) 0.93
Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol (1985) 0.93
Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest (1981) 0.92
Role of local gamma-A-immunoglobulins in immunity. Am J Dis Child (1968) 0.92
Live attenuated bacterial vaccines: new approaches for safety and efficacy. Lancet (1985) 0.92
Paraneoplastic pemphigus in children and adolescents. Br J Dermatol (2002) 0.92
Acute glomerulonephritis associated with normal serum B1C-globulin. Am J Dis Child (1968) 0.92
Herpes simplex encephalitis: brain biopsy and treatment with 5-iodo-2'-deoxyuridine. J Pediatr (1968) 0.91
Idiopathic pulmonary hemosiderosis: ultrastructural studies and responses to azathioprine. Arch Intern Med (1976) 0.91
Maturation of the rabbit alveolar macrophage during animal development. II. Biochemical and enzymatic studies. Pediatr Res (1977) 0.91
Severe candidiasis associated with thymic dysplasia, IgA deficiency, and plasma antilyMPHOCYTE EFFECTS. Pediatrics (1970) 0.91
Impaired cellular immunity to rubella virus in congenital rubella. Infect Immun (1974) 0.90
Pemphigus and pemphigoid antigens are expressed in human amnion epithelium. J Invest Dermatol (1984) 0.90
Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol (1986) 0.89
Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol (1983) 0.89
Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol (1994) 0.89
The IgM response of children to Salmonella typhosa vaccine. I. Measurements of anti-typhoid concentrations and their proportions of total serum IgM globulins. J Immunol (1969) 0.89
Pathogenesis of scleroderma. Current concepts. Int J Dermatol (1984) 0.89
Diagnostic value of IgG4 measurements in patients with food allergy. Ann Allergy (1989) 0.88
Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol (1999) 0.88
Immunohistochemical abnormalities of fibrillin in cardiovascular tissues in Marfan's syndrome. Ann Thorac Surg (1997) 0.88
Ibuprofen modifies the inflammatory response of the murine lung to Pseudomonas aeruginosa. Eur J Respir Dis (1985) 0.86
Studies of the relationship of the 230-kD and 180-kD bullous pemphigoid antigens. J Invest Dermatol (1990) 0.86
Paraneoplastic pemphigus with a pemphigus vegetans-like plaque as the only cutaneous manifestation. J Am Acad Dermatol (1998) 0.86
Animal models for bullous pemphigoid. Clin Dermatol (1987) 0.86
Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. J Am Acad Dermatol (1987) 0.86